Emerging pharmacological therapies for prevention and early treatment of acute lung injury

Seminars in Respiratory and Critical Care Medicine

Volumn 34, Issue 4, 2013, Pages 448-458

  Ortiz Diaz, Enrique ^a   Festic, Emir ^b   Gajic, Ognjen ^a   Levitt, Joseph E ^c  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

acute lung injury; acute respiratory distress syndrome; lung injury prediction score; multiorgan dysfunction syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CURCUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STEROID;

ACIDOSIS; ACUTE ABDOMEN; ACUTE LUNG INJURY; ALCOHOL ABUSE; ARTICLE; ASPIRATION; BRAIN INJURY; DIABETES MELLITUS; FRACTURE; HIGH RISK PATIENT; HUMAN; HYPOALBUMINEMIA; LUNG CONTUSION; NEAR DROWNING; OBESITY; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; SHOCK; TACHYPNEA;

ACUTE LUNG INJURY; ANIMALS; DRUG DESIGN; HUMANS; MOLECULAR TARGETED THERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; TIME FACTORS;

EID: 84881570747     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0033-1351118     Document Type: Article

References (105)

1. Rubenfeld G. D., Herridge M. S. Epidemiology and outcomes of acute lung injury. Chest: 2007; 131 2 554 562 (Pubitemid 46280419)
2. Phua J., Badia J. R., Adhikari N. K., et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med: 2009; 179 3 220 227
3. Li G., Malinchoc M., Cartin-Ceba R., et al. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med: 2011; 183 1 59 66
4. Wilcox M. E., Herridge M. S. Long-term outcomes in patients surviving acute respiratory distress syndrome. Semin Respir Crit Care Med: 2010; 31 1 55 65
5. Bosma K. J., Taneja R., Lewis J. F. Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experemental approaches. Drugs: 2010; 70 10 1255 1282
6. Cepkova M., Matthay M. A. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med: 2006; 21 3 119 143
7. Levitt J. E., Bedi H., Calfee C. S., Gould M. K., Matthay M. A. Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure. Chest: 2009; 135 4 936 943
8. Gajic O., Dabbagh O., Park P. K., et al. on behalf of the U.S. Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG-LIPS) Early identification of patients at risk of acute lung injury evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med: 2011; 183 462 470
9. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med: 2000; 342 18 1301 1308
10. Eder A. F., Herron R. M. Jr, Strupp A., et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion: 2010; 50 8 1732 1742
11. Gajic O., Dara S. I., Mendez J. L., et al. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med: 2004; 32 9 1817 1824 (Pubitemid 39202355)
12. Iscimen R., Cartin-Ceba R., Yilmaz M., et al. Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med: 2008; 36 5 1518 1522 (Pubitemid 351620653)
13. Yilmaz M., Keegan M. T., Iscimen R., et al. Toward the prevention of acute lung injury: protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion. Crit Care Med: 2007; 35 7 1660 1666, quiz 1667 (Pubitemid 46985866)
14. Hou P. CJ, Elie-Turenne M., et al. A survey on behalf of USCIITG-LIPS Investigators: towards standardization of a Checklist for Lung Injury Prevention (CLIP). Crit Care Med: 2010;; Supplement a576
15. Levi M., van der Poll T. Inflammation and coagulation. Crit Care Med: 2010; 38 (2, Suppl): S26 S34
16. Laterre P. F., Wittebole X., Dhainaut J. F. Anticoagulant therapy in acute lung injury. Crit Care Med: 2003; 31 (4, Suppl): S329 S336 (Pubitemid 36458188)
17. Asaduzzaman M., Lavasani S., Rahman M., et al. Platelets support pulmonary recruitment of neutrophils in abdominal sepsis. Crit Care Med: 2009; 37 4 1389 1396
18. Yiming M. T., Lederer D. J., Sun L., Huertas A., Issekutz A. C., Bhattacharya S. Platelets enhance endothelial adhesiveness in high tidal volume ventilation. Am J Respir Cell Mol Biol: 2008; 39 5 569 575
19. Zarbock A., Ley K. The role of platelets in acute lung injury (ALI). Front Biosci: 2009; 14 150 158
20. Bozza F. A., Shah A. M., Weyrich A. S., Zimmerman G. A. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol: 2009; 40 2 123 134
21. Lösche W., Boettel J., Kabisch B., Winning J., Claus R. A., Bauer M. Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients? Thrombosis: 2012; 2012 720254
22. Song C., Suzuki S., Kubo H., et al. Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats. Thorax: 2004; 59 1 39 44 (Pubitemid 38067970)
23. Looney M. R., Nguyen J. X., Hu Y., Van Ziffle J. A., Lowell C. A., Matthay M. A. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest: 2009; 119 11 3450 3461
24. Chelucci G. L., Boncinelli S., Marsili M., et al. Aspirin effect on early and late changes in acute lung injury in sheep. Intensive Care Med: 1993; 19 1 13 21 (Pubitemid 23081479)
25. Erlich J. M., Talmor D. S., Cartin-Ceba R., Gajic O., Kor D. J. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest: 2011; 139 2 289 295
26. O'Neal H. R. Jr, Koyama T., Koehler E. A., et al. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med: 2011; 39 6 1343 1350
27. Kor D. J., Erlich J., Gong M. N., et al. U.S. Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients. Crit Care Med: 2011; 39 11 2393 2400
28. Tyrrell D. J., Horne A. P., Holme K. R., Preuss J. M., Page C. P. Heparin in inflammation: potential therapeutic applications beyond anticoagulation. Adv Pharmacol: 1999; 46 151 208
29. Young E. The anti-inflammatory effects of heparin and related compounds. Thromb Res: 2008; 122 6 743 752
30. Suter P. M. Nebulised heparin: a new approach to the treatment of acute lung injury? Crit Care: 2008; 12 4 170
31. Enkhbaatar P., Cox R. A., Traber L. D., et al. Aerosolized anticoagulants ameliorate acute lung injury in sheep after exposure to burn and smoke inhalation. Crit Care Med: 2007; 35 12 2805 2810 (Pubitemid 350175779)
32. Enkhbaatar P., Esechie A., Wang J., et al. Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation. Clin Sci (Lond): 2008; 114 4 321 329 (Pubitemid 351294008)
33. Murakami K., McGuire R., Cox R. A., et al. Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock: 2002; 18 3 236 241
34. Cox C. S. Jr, Zwischenberger J. B., Traber D. L., Traber L. D., Haque A. K., Herndon D. N. Heparin improves oxygenation and minimizes barotrauma after severe smoke inhalation in an ovine model. Surg Gynecol Obstet: 1993; 176 4 339 349 (Pubitemid 23097953)
35. Tasaki O., Mozingo D. W., Dubick M. A., Goodwin C. W., Yantis L. D., Pruitt B. A. Jr. Effects of heparin and lisofylline on pulmonary function after smoke inhalation injury in an ovine model. Crit Care Med: 2002; 30 3 637 643 (Pubitemid 34214630)
36. Miller A. C., Rivero A., Ziad S., Smith D. J., Elamin E. M. Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury. J Burn Care Res: 2009; 30 2 249 256
37. Desai M. H., Mlcak R., Richardson J., Nichols R., Herndon D. N. Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine [correction of acetylcystine] therapy. J Burn Care Rehabil: 1998; 19 3 210 212 (Pubitemid 28237673)
38. Holt J., Saffle J. R., Morris S. E., Cochran A. Use of inhaled heparin/N-acetylcystine in inhalation injury: does it help? J Burn Care Res: 2008; 29 1 192 195
39. Thompson B. T. Corticosteroids for ARDS. Minerva Anestesiol: 2010; 76 6 441 447
40. Barnes P. J. Corticosteroids: the drugs to beat. Eur J Pharmacol: 2006; 533 1-3 2 14 (Pubitemid 43340000)
41. Marik P. E., Meduri G. U., Rocco P. R., Annane D. Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome. Crit Care Clin: 2011; 27 3 589 607
42. Abe M., Goya T., Mitsuyama T., Torisu M., Furukawa T. Evaluation of the effects of steroids on experimental septic lung injury. Prostaglandins Leukot Essent Fatty Acids: 1996; 54 2 123 128 (Pubitemid 26111251)
43. Chen C. M., Wang L. F., Su B., Hsu H. H. Methylprednisolone effects on oxygenation and histology in a rat model of acute lung injury. Pulm Pharmacol Ther: 2003; 16 4 215 220 (Pubitemid 36794387)
44. Kuwabara K., Furue S., Tomita Y., et al. Effect of methylprednisolone on phospholipase A(2) activity and lung surfactant degradation in acute lung injury in rabbits. Eur J Pharmacol: 2001; 433 2-3 209 216 (Pubitemid 34045181)
45. Shiue S. T., Thrall R. S. Effect of corticosteroid therapy on the acute injury and recovery stage of oleic acid induced lung injury in the rat. Exp Lung Res: 1991; 17 3 629 638
46. Modig J., Borg T. High-dose methylprednisolone in a porcine model of ARDS induced by endotoxemia. Acta Chir Scand Suppl: 1985; 526 94 103 (Pubitemid 16158505)
47. Butler R. R. Jr, Spicer K. M. Indomethacin and dexamethasone decrease oleic acid-induced pulmonary protein leak in rabbits. Circ Shock: 1986; 20 3 217 229 (Pubitemid 17189940)
48. Cheney F. W. Jr, Huang T. H., Gronka R. Effects of methylprednisolone on experimental pulmonary injury. Ann Surg: 1979; 190 2 236 242 (Pubitemid 9254979)
49. Jansen N. J., van Oeveren W., Hoiting B. H., Wildevuur C. R. Methylprednisolone prophylaxis protects against endotoxin-induced death in rabbits. Inflammation: 1991; 15 2 91 101
50. Gates S., Huang T., Cheney F. W. Effects of methylprednisolone on resolution of acid-aspiration pneumonitis. Arch Surg: 1983; 118 11 1262 1265 (Pubitemid 13022375)
51. Hamelberg W., Bosomworth P. P. Aspiration pneumonitis: experimental studies and clinical observations. Anesth Analg: 1964; 43 669 677
52. Bone R. C., Fisher C. J. Jr, Clemmer T. P., Slotman G. J., Metz C. A. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest: 1987; 92 6 1032 1036 (Pubitemid 18026542)
53. Weigelt J. A., Norcross J. F., Borman K. R., Snyder W. H. III. Early steroid therapy for respiratory failure. Arch Surg: 1985; 120 5 536 540 (Pubitemid 15053408)
54. Bernard G. R., Luce J. M., Sprung C. L., et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med: 1987; 317 25 1565 1570 (Pubitemid 18014383)
55. Luce J. M., Montgomery A. B., Marks J. D., Turner J., Metz C. A., Murray J. F. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis: 1988; 138 1 62 68
56. Peter J. V., John P., Graham P. L., Moran J. L., George I. A., Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ: 2008; 336 7651 1006 1009 (Pubitemid 351656093)
57. Lee H. S., Lee J. M., Kim M. S., Kim H. Y., Hwangbo B., Zo J. I. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Ann Thorac Surg: 2005; 79 2 405 410 (Pubitemid 40186527)
58. Annane D., Sébille V., Bellissant E. Ger-Inf-05 Study Group Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med: 2006; 34 1 22 30 (Pubitemid 43032376)
59. Confalonieri M., Urbino R., Potena A., et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med: 2005; 171 3 242 248
60. Forsgren P. E., Modig J. A., Dahlbäck C. M., Axelsson B. I. Prophylactic treatment with an aerosolized corticosteroid liposome in a porcine model of early ARDS induced by endotoxaemia. Acta Chir Scand: 1990; 156 6-7 423 431 (Pubitemid 20188402)
61. Walther S., Jansson I., Berg S., Lennquist S. Pulmonary granulocyte accumulation is reduced by nebulized corticosteroid in septic pigs. Acta Anaesthesiol Scand: 1992; 36 7 651 655
62. Walther S., Jansson I., Berg S., Olsson Rex L., Lennquist S. Corticosteroid by aerosol in septic pigs-effects on pulmonary function and oxygen transport. Intensive Care Med: 1993; 19 3 155 160 (Pubitemid 23193708)
63. Wang J., Zhang L., Walther S. M. Inhaled budesonide in experimental chlorine gas lung injury: influence of time interval between injury and treatment. Intensive Care Med: 2002; 28 3 352 357 (Pubitemid 34230659)
64. Jansson A-H, Eriksson C., Wang X. Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats. Vascul Pharmacol: 2005; 43 2 101 111 (Pubitemid 40981938)
65. Smith A., Brown R., Jugg B., et al. The effect of steroid treatment with inhaled budesonide or intravenous methylprednisolone on phosgene-induced acute lung injury in a porcine model. Mil Med: 2009; 174 12 1287 1294
66. Ortiz-Diaz E., Li G., Kor D., et al. Preadmission use of inhaled corticosteroids is associated with a reduced risk of direct acute lung injury/acute respiratory distress syndrome. Chest: 2011; 140 912A
67. Karnatovskaia L. V., Lee A. S., Gajic O., Festic E. The influence of prehospital systemic corticosteroid use on development of acute respiratory distress syndrome and hospital outcomes. Crit Care Med: 2013; May 8 (e-pub ahead of print). 10.1097/CCM.0b013e31828a1fc7
68. Berthiaume Y., Matthay M. A. Alveolar edema fluid clearance and acute lung injury. Respir Physiol Neurobiol: 2007; 159 3 350 359 (Pubitemid 350123611)
69. Matthay M. A., Folkesson H. G., Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev: 2002; 82 3 569 600 (Pubitemid 34743332)
70. McAuley D. F., Frank J. A., Fang X., Matthay M. A. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med: 2004; 32 7 1470 1476 (Pubitemid 38925174)
71. Khimenko P. L., Barnard J. W., Moore T. M., Wilson P. S., Ballard S. T., Taylor A. E. Vascular permeability and epithelial transport effects on lung edema formation in ischemia and reperfusion. J Appl Physiol: 1994; 77 3 1116 1121 (Pubitemid 24299360)
72. Khimenko P. L., Barnard J. W., Moore T. M., Wilson P. S., Ballard S. T., Taylor A. E. Vascular permeability and epithelial transport effects on lung edema formation in ischemia and reperfusion. J Appl Physiol: 1994; 77 3 1116 1121 (Pubitemid 24299360)
73. Frank A. J., Thompson B. T. Pharmacological treatments for acute respiratory distress syndrome. Curr Opin Crit Care: 2010; 16 1 62 68
74. Perkins G. D., McAuley D. F., Richter A., Thickett D. R., Gao F. Bench-to-bedside review: beta2-Agonists and the acute respiratory distress syndrome. Crit Care: 2004; 8 1 25 32 (Pubitemid 38195567)
75. Perkins G. D., McAuley D. F., Thickett D. R., Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med: 2006; 173 3 281 287 (Pubitemid 43209082)
76. Sartori C., Allemann Y., Duplain H., et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med: 2002; 346 21 1631 1636 (Pubitemid 34755671)
77. 2-agonist for treatment of acute lung injury. Am J Respir Crit Care Med: 2011; 184 5 561 568
78. Gao Smith F., Perkins G. D., Gates S., et al. BALTI-2 study investigators Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet: 2012; 379 9812 229 235
79. Terblanche M., Almog Y., Rosenson R. S., Smith T. S., Hackam D. G. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis: 2007; 7 5 358 368 (Pubitemid 46590065)
80. Kouroumichakis I., Papanas N., Proikaki S., Zarogoulidis P., Maltezos E. Statins in prevention and treatment of severe sepsis and septic shock. Eur J Intern Med: 2011; 22 2 125 133
81. Kopterides P., Falagas M. E. Statins for sepsis: a critical and updated review. Clin Microbiol Infect: 2009; 15 4 325 334
82. Bajwa E. K., Malhotra C. K., Thompson B. T., Christiani D. C., Gong M. N. Statin therapy as prevention against development of acute respiratory distress syndrome: an observational study. Crit Care Med: 2012; 40 5 1470 1477
83. Craig T. R., Duffy M. J., Shyamsundar M., et al. A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med: 2011; 183 5 620 626
84. Honiden S., Gong M. N. Diabetes, insulin, and development of acute lung injury. Crit Care Med: 2009; 37 8 2455 2464
85. Imai Y., Kuba K., Penninger J. M. Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Cell Mol Life Sci: 2007; 64 15 2006 2012 (Pubitemid 47094425)
86. Kuba K., Imai Y., Penninger J. M. Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol: 2006; 6 3 271 276 (Pubitemid 43670913)
87. Yao S., Feng D., Wu Q., Li K., Wang L. Losartan attenuates ventilator-induced lung injury. J Surg Res: 2008; 145 1 25 32 (Pubitemid 351221087)
88. Bechara R. I., Pelaez A., Palacio A., et al. Angiotensin II mediates glutathione depletion, transforming growth factor-beta1 expression, and epithelial barrier dysfunction in the alcoholic rat lung. Am J Physiol Lung Cell Mol Physiol: 2005; 289 3 L363 L370 (Pubitemid 41192710)
89. Gong M. N., Bajwa E. K., Thompson B. T., Christiani D. C. Use of ACE inhibitors and development and outcome in ARDS. Am J Respir Crit Care Med: 2009; 179 A5095
90. Trillo-Alvarez C. A., Kashyap R., Kojicic M., et al. Chronic use of angiotensin pathway inhibitors is associated with a decreased risk of acute respiratory distress syndrome [abstract]. Am J Respir Crit Care Med: 2009; 179 A4638
91. Watkins T. R., Lemos-Filho L., Dabbagh O., Chang S. Y., Park P. K., Gong M. N. on behalf of USIITG-LIPS. Use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers and clinical outcomes among patients at-risk for acute lung injury. Presented at American Thoracic Society 2011 International Conference Vol 183 Meeting Abstracts
92. Paola R. D., Cuzzocrea S. Peroxisome proliferator-activated receptors and acute lung injury. PPAR Res: 2007; 2007 63745
93. Becker J., Delayre-Orthez C., Frossard N., Pons F. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? Fundam Clin Pharmacol: 2006; 20 5 429 447 (Pubitemid 44393958)
94. Schaefer M. B., Pose A., Ott J., et al. Peroxisome proliferator-activated receptor-alpha reduces inflammation and vascular leakage in a murine model of acute lung injury. Eur Respir J: 2008; 32 5 1344 1353
95. Liu D., Zeng B. X., Zhang S. H., et al. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats. Crit Care Med: 2005; 33 10 2309 2316 (Pubitemid 41437486)
96. Chen C., Xu S., Wang W. X., et al. Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury. Arch Med Res: 2009; 40 2 79 88
97. Aoki Y., Maeno T., Aoyagi K., et al. Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis. Respiration: 2009; 77 3 311 319
98. Chima R. S., Hake P. W., Piraino G., Mangeshkar P., Denenberg A., Zingarelli B. Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock. Crit Care Med: 2008; 36 10 2849 2857
99. Moss M., Guidot D. M., Steinberg K. P., et al. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med: 2000; 28 7 2187 2192 (Pubitemid 30604414)
100. Leitman I. M. Curcumin for the prevention of acute lung injury in sepsis: is it more than the flavor of the month? J Surg Res: 2011; 20 20
101. Venkatesan N., Punithavathi D., Babu M. Protection from acute and chronic lung diseases by curcumin. Adv Exp Med Biol: 2007; 595 379 405
102. Suresh M. V., Wagner M. C., Rosania G. R., et al. Pulmonary administration of water-soluble curcumin complex reduces ALI severity. Am J Respir Cell Mol Biol: 2012; 3 3
103. Bansal S., Chhibber S. Curcumin alone and in combination with augmentin protects against pulmonary inflammation and acute lung injury generated during Klebsiella pneumoniae B5055-induced lung infection in BALB/c mice. J Med Microbiol: 2010; 59 Pt 4 429 437
104. Sun J., Yang D., Li S., Xu Z., Wang X., Bai C. Effects of curcumin or dexamethasone on lung ischaemia-reperfusion injury in rats. Eur Respir J: 2009; 33 2 398 404
105. Liu K., Shen L., Wang J., et al. The preventative role of curcumin on the lung inflammatory response induced by cardiopulmonary bypass in rats. J Surg Res: 2010; 31 31